Changing the glucose cut-off values that define hypoglycaemia has a major effect on reported frequencies of hypoglycaemia
The aim of this analysis was to quantify the relationship between the frequency of hypoglycaemia and various glucose cut-off points for the definition of hypoglycaemia, within a range of HbA1c strata.
Data from two trials examining insulin glargine dose titration in 12,837 type 2 diabetic participants starting insulin therapy were combined. Curves for hypoglycaemia frequency plotted against endpoint HbA1c level were constructed, using a range of glucose cut-off points for hypoglycaemia.
During the 12-week study period, 3,912 patients recorded 21,592 hypoglycaemic episodes, comprising 242 severe, 8,871 symptomatic and 12,479 asymptomatic events, corresponding to hypoglycaemia event rates of 0.10, 3.8 and 5.3 events per patient year. Increasing the hypoglycaemia cut-off point from, for instance, <3.1 to <3.9 mmol/l more than doubled the percentage of affected patients, e.g. from 17.7 to 43.3% at HbA1c 7.0–7.2%. At higher hypoglycaemia cut-off points the proportion of patients having only asymptomatic hypoglycaemia increased, e.g. from 30.7% at <3.1 mmol/l to 61.7% of patients at a cut-off point of <3.9 mmol/l. In sensitivity analysis, 121 of 1,756 patients with at least one self-monitored blood glucose value <3.1 mmol/l experienced severe hypoglycaemia, compared with 149 of 3,912 patients with a self-monitored blood glucose level of <3.9 mmol/l. Thus, to identify 28 more patients with severe hypoglycaemia, the number of patients experiencing only non-severe hypoglycaemia more than doubled.
The glucose cut-off point defining hypoglycaemia greatly affects the reported frequency of hypoglycaemia. When hypoglycaemia is to be defined by a predetermined glucose level, to have clinical relevance the cut-off should be set at a lower level than the threshold of 3.9 mmol/l proposed by the American Diabetes Association.
- American Diabetes Association Workgroup on Hypoglycemia (2005) Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia. Diabetes Care 28:1245–1249 CrossRef
- Amiel SA, Dixon T, Mann R, Jameson K (2008) Hypoglycaemia in type 2 diabetes. Diabet Med 25:245–254 CrossRef
- Kennedy L, Herman WH, Strange P, Harris A, for the GOAL A1C Team (2006) Impact of active versus usual algorithmic titration of basal insulin and point-of-care versus laboratory measurement of HbA1c on glycemic control in patients with type 2 diabetes: The Glycemic Optimization with Algorithms and Labs at Point of Care (GOAL A1C) trial. Diabetes Care 29:1–8 CrossRef
- Gold AE, MacLeod KM, Frier BM (1994) Frequency of severe hypoglycemia in patients with type I diabetes with impaired awareness of hypoglycemia. Diabetes Care 17:697–703 CrossRef
- Kubiak T, Hermanns N, Schreckling HJ, Kulzer B, Haak T (2004) Assessment of hypoglycaemia awareness using continuous glucose monitoring. Diabet Med 21:487–490 CrossRef
- UK Prospective Diabetes Study (UKPDS) Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837–853 CrossRef
- UK Hypoglycaemia Study Group (2007) Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration. Diabetologia 50:1140–1114 CrossRef
- Donnelly LA, Morris AD, Frier BM et al (2005) Frequency and predictors of hypoglycaemia in type 1 and insulin-treated type 2 diabetes: a population-based study. Diabet Med 22:749–755 CrossRef
- MacLeod KM, Hepburn DA, Frier BM (1993) Frequency and morbidity of severe hypoglycaemia in insulin-treated diabetic patients. Diabet Med 10:238–245 CrossRef
- Henderson JN, Allen KV, Deary IJ, Frier BM (2003) Hypoglycaemia in insulin-treated type 2 diabetes: frequency, symptoms and impaired awareness. Diabet Med 20:1016–1021 CrossRef
- Changing the glucose cut-off values that define hypoglycaemia has a major effect on reported frequencies of hypoglycaemia
- Open Access
- Available under Open Access This content is freely available online to anyone, anywhere at any time.
Volume 52, Issue 1 , pp 38-41
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Type 2 diabetes
- Industry Sectors
- Author Affiliations
- 1. Department of Internal Medicine, Academic Medical Centre, Meibergdreef 9, Room F4-257, 1105 AZ, Amsterdam, the Netherlands
- 2. Department of Statistics, University of Auckland, Auckland, New Zealand
- 3. Department of Biostatistics, Sanofi Aventis, Bridgewater, NJ, USA